Lyrica (pregabalin) is not clearly safer than gabapentin. Both drugs belong to the same class, called gabapentinoids, and they share most of the same side effects, warnings, and risks. The meaningful differences between them have less to do with overall safety and more to do with how the body absorbs each drug, how tightly each one is regulated, and how they behave in specific situations like kidney disease or combination with other medications.
How the Two Drugs Compare
Pregabalin and gabapentin work the same way in the brain, calming overactive nerve signals involved in seizures, nerve pain, and conditions like fibromyalgia. They’re both FDA-approved to treat partial seizures and several types of nerve pain, including pain from shingles, spinal cord injury, and diabetes. Pregabalin also has an FDA approval for fibromyalgia and restless legs syndrome, which gives it a slightly broader official range of uses.
The key pharmacological difference is potency. Clinicians use a roughly 6:1 conversion ratio when switching between the two: 300 mg of gabapentin is equivalent to about 50 mg of pregabalin. That means pregabalin achieves the same effect at a much smaller dose. This isn’t inherently safer or more dangerous, but it does mean dosing errors with pregabalin can have outsized consequences.
Gabapentin also has an unusual absorption quirk. Your gut can only absorb so much gabapentin at a time, so as the dose increases, a smaller percentage actually makes it into your bloodstream. Pregabalin doesn’t have this limitation. Its absorption is more predictable and consistent regardless of dose, which is one reason some prescribers prefer it. But that same predictability also means pregabalin’s effects ramp up more reliably, which contributes to its higher abuse potential.
Side Effects Are Similar for Both
The most common side effects of both drugs are dizziness, drowsiness, and swelling in the legs or feet. These occur at comparable rates and are dose-dependent, meaning they get worse as you take more. Both drugs can also cause weight gain, blurred vision, dry mouth, and difficulty concentrating.
Neither drug has a significantly milder side effect profile than the other at equivalent doses. If you experience problematic side effects on one, switching to the other sometimes helps because individual body chemistry varies, but there’s no guarantee.
Abuse Potential Differs Significantly
This is one area where the two drugs are not equivalent. Pregabalin is a Schedule V controlled substance under federal law, the least restrictive category but still a controlled substance. Gabapentin is not federally scheduled at all, though several U.S. states have added their own controls.
The scheduling difference reflects real-world data. FDA adverse event reports show a higher proportion of abuse-related cases for pregabalin (10.2% of reports) compared to gabapentin (5.7%). Pregabalin produces a more noticeable euphoric effect for some people, particularly at higher doses, and its more predictable absorption likely plays a role. If you have a history of substance use issues, this distinction matters and is worth discussing with your prescriber.
Breathing Risks When Combined With Other Drugs
The FDA has issued safety warnings for both pregabalin and gabapentin regarding serious breathing problems. The risk is highest when either drug is taken alongside opioids, benzodiazepines, or other central nervous system depressants. This warning applies equally to both medications.
People with existing respiratory conditions like COPD or sleep apnea face elevated risk with either gabapentinoid, even without other medications in the mix. The breathing risk is not unique to one drug over the other.
Fall Risk in Older Adults
Both gabapentinoids increase fall risk in older adults, and the risk may be comparable to that of opioids. They cause sleepiness, dizziness, and confusion, all of which make falls more likely. Gabapentin specifically can worsen the problem by causing leg swelling that impairs mobility on top of the cognitive effects.
There’s no strong evidence that one gabapentinoid is meaningfully safer than the other for people over 65. The general recommendation is to use the lowest effective dose of whichever one is prescribed and to be especially cautious about combining it with other sedating medications.
Kidney Function Changes the Equation
Both drugs are eliminated almost entirely by the kidneys, so reduced kidney function means the drug builds up in your body and side effects intensify. Both require dose reductions as kidney function declines, following specific thresholds based on creatinine clearance.
For someone with normal kidney function (creatinine clearance above 79 mL/min), the maximum daily dose is 3,600 mg for gabapentin and 600 mg for pregabalin. At severe impairment (creatinine clearance below 15), those maximums drop to 300 mg and 75 mg respectively, often given only three times per week after dialysis. The proportional reductions are roughly similar for both drugs, so neither has a clear kidney-safety advantage.
That said, because pregabalin’s absorption is more predictable, some clinicians find it easier to dose accurately in patients with kidney problems. Gabapentin’s inconsistent absorption can make it harder to predict how much drug is actually reaching the bloodstream, which complicates dosing in people who are already sensitive to accumulation.
Stopping Either Drug Requires a Taper
Neither pregabalin nor gabapentin should be stopped abruptly. Withdrawal symptoms from both include anxiety, insomnia, nausea, pain, and sweating. The general recommendation is to taper over at least one week, though longer tapers are common for people who have been on higher doses or have taken the medication for months or years.
Pregabalin withdrawal may feel more acute for some people because of its higher potency and more consistent blood levels. Your body can become more thoroughly accustomed to a drug that maintains steady levels, so the adjustment when it’s removed can be sharper. But both drugs require the same careful, gradual approach to discontinuation.
Which One Is Right for You
The choice between pregabalin and gabapentin typically comes down to the specific condition being treated, how your body responds, and your individual risk factors rather than one drug being broadly “safer.” Pregabalin offers more predictable absorption and fewer daily doses (usually twice a day versus three times for gabapentin), which some people find more convenient. Gabapentin carries a lower abuse risk and is available as a generic at lower cost.
If you’re concerned about dependency, gabapentin’s lower abuse potential is a genuine advantage. If you have kidney problems, the dosing considerations are similar for both. If you take opioids or other sedating medications, neither drug is safer than the other, and both require extra caution. The safety profiles are close enough that the better question isn’t which drug is safer in the abstract, but which one is safer for your specific situation.